Market Overview

Why Evofem Biosciences Is Trading Lower Today


Evofem Biosciences (NASDAQ: EVFM) shares were trading lower on Friday after the company's CEO sold 122,500 shares at an average price of $3.26.

Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.

Its focus is to advance the quality of life for women by developing solutions such as hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections.

Evofem Biosciences shares were trading down 18.01% at $2.23 during the time of publication on Friday. The stock has a 52-week high of $7.50 and a 52-week low of $2.23.


Related Articles (EVFM)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Health Care Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at